Advanced Biomed Inc.
ADVB· Nasdaq
Filed Oct 8, 2025 · 10-K · 100 days after period end · 0001213900-25-097465
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures |
|---|---|---|
| Net Income | -$701.61K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Advanced Biomed Inc. · CIK 1941029 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Oct 8, 2025 · 100 d after period end